Literature DB >> 20889284

Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: a cohort study.

Jorge I F Salluh1, Márcio Soares, Luis M Coelho, Fernando A Bozza, Juan Carlos R Verdeal, Hugo C Castro-Faria-Neto, José Roberto Lapa e Silva, Patrícia T Bozza, Pedro Póvoa.   

Abstract

INTRODUCTION: Our aim was to evaluate the impact of corticosteroids on clinical course and outcomes of patients with severe community-acquired pneumonia (CAP) requiring invasive mechanical ventilation.
METHODS: This was a cohort study of patients with severe CAP from 2 intensive care units in tertiary hospitals in Brazil and Portugal.
RESULTS: A total of 111 patients were included (median age, 69 years; 56% men; 34% hospital mortality). Corticosteroids were prescribed in 61 (55%) patients. Main indications for their use were bronchospasm (52.5%) and septic shock (36%). Mortality rate of patients treated with and without corticosteroids was comparable (29.5% vs 32%, P = .837). No significant differences were observed on clinical course from day 1 to day 7 as assessed by the Sequential Organ Failure Assessment score (P = .95). Furthermore, C-reactive protein declined similarly in both groups (P = .147). In a multivariate analysis, mortality was associated with older age and higher Acute Physiology and Chronic Health Evaluation II score.
CONCLUSIONS: In patients with severe CAP requiring invasive mechanical ventilation, adjunctive therapy with corticosteroids did not influence intensive care unit and hospital mortality. In addition, no changes were observed on weaning from vasopressors, on recovery from organ failure/dysfunction as assessed by the Sequential Organ Failure Assessment score, as well as on C-reactive protein course.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20889284     DOI: 10.1016/j.jcrc.2010.07.014

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  15 in total

1.  C-reactive protein in community-acquired sepsis: you can teach new tricks to an old dog.

Authors:  Jorge I F Salluh; Thiago Lisboa
Journal:  Crit Care       Date:  2011-09-07       Impact factor: 9.097

2.  Evaluation of Systemic Corticosteroids in Patients With an Acute Exacerbation of COPD and a Diagnosis of Pneumonia.

Authors:  Tyler Scholl; Tyree H Kiser; Sheryl F Vondracek
Journal:  Chronic Obstr Pulm Dis       Date:  2018-01-24

Review 3.  Community-acquired pneumonia: identification and evaluation of nonresponders.

Authors:  João Gonçalves-Pereira; Catarina Conceição; Pedro Póvoa
Journal:  Ther Adv Infect Dis       Date:  2013-02

4.  Use of biomarkers in sepsis: many questions, few answers.

Authors:  Pedro Póvoa; Jorge Ibrain Figueira Salluh
Journal:  Rev Bras Ter Intensiva       Date:  2013-03

5.  Corticosteroids in severe community-acquired pneumonia: the path we choose depends on where we want to get.

Authors:  Jorge I F Salluh; Márcio Soares; Pedro Póvoa
Journal:  Crit Care       Date:  2011-03-24       Impact factor: 9.097

Review 6.  Clinical Utility and Measurement of Procalcitonin.

Authors:  Intan Samsudin; Samuel D Vasikaran
Journal:  Clin Biochem Rev       Date:  2017-04

7.  Corticosteroids for pneumonia: are we there yet?

Authors:  Oriol Sibila; Marcos I Restrepo
Journal:  Respirology       Date:  2013-02       Impact factor: 6.424

8.  The ARREST Pneumonia Clinical Trial. Rationale and Design.

Authors:  Joseph E Levitt; Emir Festic; Manisha Desai; Haley Hedlin; Kenneth W Mahaffey; Angela J Rogers; Ognjen Gajic; Michael A Matthay
Journal:  Ann Am Thorac Soc       Date:  2021-04

9.  Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; Navneet Singh; Narayan Mishra; G C Khilnani; J K Samaria; S N Gaur; S K Jindal
Journal:  Lung India       Date:  2012-07

10.  Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis.

Authors:  Wei Nie; Yi Zhang; Jinwei Cheng; Qingyu Xiu
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.